Strategies to generate tumor-specific T cells for adoptive transfer include the expression of chimeric antigen receptors (CARs), which are able to recognize antigen epitopes independently of MHC presentation, or the transduction with T cell receptors (TCRs) that target a specific tumor antigen. The gene discussed is HLA-C; the disease is neoplasm.